BioSpace News Archive

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce the appointment of Dr. Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology (NGIO) Board of Directors.

OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the pricing of its underwritten public offering of 1,570,000 shares of its common stock at a price to the public of $36.50 per share.

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), (“Marinus” or the “Company”) today announced the pricing of an underwritten public offering of 28,000,000 shares of common stock at a public offering price of $1.25 per share.

Partners Jim O’Sullivan, Jacob Sack, and Stephanie Maistrellis, and Principals Mariah Lang and Sophia Mowla Specialize in Recruiting Game-Changing Executives for Modern Healthcare and Life Sciences Companies [11-December-2019] BOSTON , Dec. 11, 2019 /PRNewswire/ -- True Search , the fastest growing search firm and 8th largest in North America , is excited to announc

Seqirus, a global leader in influenza prevention, announced today that its cell-based quadrivalent influenza vaccine (QIVc) has received approval from Health Canada for use in people 9 years of age and older.

Voters More Likely to Support a Candidate Who Promises to Address Mental Health and Addiction, According to New Polling from the National Council for Behavioral Health Released Ahead of December 16 New Hampshire 2020 Presidential Candidate Forum

Chenoweth Partners with BioDelivery Sciences to End Stigma Around Chronic Pain and Inspire Positive Change for Patients

The new product is the generic equivalent to Ivanz®.

People who use eHealth’s online health plan comparison tool are twice as likely to enroll

New Research from XIFIN and Journal of Precision Medicine Yields Promising Findings on the Value of PMI Initiatives